Dianthus Therapeutics | MGTA - Eigenkapital Und Reserven

Aktienkurs
86.92
Täglich Wechseln
7.69 9.71%
Monatlich
74.12%
Jährlich
271.77%
Q1 Prognose
63.23




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Avita Medical AUD -16.65M 3.76M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 8.65B 680M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 349.13M 36.37M 2025-09
Organon & Co USD 906M 173M 2025-09
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pharma Mar EUR 251.83M 54.32M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Tilray USD 1.51B 1.22B 2025-03
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD -861K 18.44M 2025-09
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09